Not Signed In - Osteotech Receives FDA Clearance For First Product Under Its Plexus Technology Platform
Fri, 09 Feb 2007 08:00 AM EST
... Osteotech, Inc. (Nasdaq: OSTE) announced today that the Food and Drug Administration ("FDA") has cleared its 510(k) submission for an osteoconductive, bone/polymer biocomposite, which will be the first commercial product manufactured under Osteotech's proprietary Plexus Technology Platform. [click link for full article] ...
Related Topics
- Creatinine Clearance
- Assistive Technology
- Brachial Plexus Injuries
- Household Poisons
- Information Systems
- Creatinine
- Consumer Product Safety
- Assisted Reproductive Technology
- Brachial Plexus
- Brachial Plexus Injury
- Brachial Plexus Neuropathy
- Brachial Plexus Birth Injuries
- Tacrolimus ointment
- Food Labeling
- Skin Care
- Mammography
- Teeth
- Food Labels
- Information Technology at the CDC
- Carcinogens
email this page
print this page
bookmark this page
feedback on this page
